Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India · Delayed Price · Currency is INR 455.05
+2.75 (0.61%)
At close: Oct 24, 2025
Gujarat Themis Biosyn Company Description
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India.
The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin.
The company was incorporated in 1981 and is based in Mumbai, India.
Gujarat Themis Biosyn Limited
| Country | India |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 221 |
| CEO | Sachin Patel |
Contact Details
Address: Themis House Mumbai, Gujarat 400104 India | |
| Phone | 91 22 6760 7080 |
| Website | gtbl.in |
Stock Details
| Ticker Symbol | GUJTHEM |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sachin Dinesh Patel CChem., Ph.D. | MD and Director |
| Bhavik Shah | Chief Financial Officer |
| Vineet Ganesh Gawankar | Company Secretary and Compliance Officer |
| Do-Seon Kim | Chief Technical Officer |
| Falguni Desai | Assistant General Manager of Human Resources |
| Rajneesh Kedarnath Anand | Senior Executive |